Dense mapping of IL2RA shows no association with Graves' disease in Chinese Han population

Clinical Endocrinology

Volumn 79, Issue 2, 2013, Pages 267-274

  Song, Zhi Yi ^a   Liu, Wei ^a   Xue, Li Qiong ^a   Pan, Chun Ming ^a   Wang, Hai Ning ^a   Gu, Zhao Hui ^b   Yang, Shao Ying ^a   Cao, Huang Ming ^a   Zuo, Chun Lin ^c   Zhang, Xiao Na ^a   Jiang, He ^a   Liu, Bing Li ^a   Bi, Ya Xin ^d   Zhang, Xiao Mei ^d   Zhao, Shuang Xia ^a   Song, Huai Dong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

^d First Affiliated Hospital of Bengbu Medical College   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR ALPHA;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MAPPING; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GRAVES DISEASE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; ETHNIC GROUPS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GRAVES DISEASE; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84880059843     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12115     Document Type: Article

References (50)

1. Hollowell, J.G., Staehling, N.W., Flanders, W.D., et al,. (2002) Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). The Journal of Clinical Endocrinology & Metabolism, 87, 489-499.
2. Chen, X., Wu, W.S., Chen, G.L., et al,. (2000) The effect of salt iodization for 10 years on the prevalences of endemic goiter and hyperthyroidism. Chinese Journal of Endocrinology Metabolism, 18, 342-344.
3. Uno, H., Sasazuki, T., Tamai, H., Matsumoto, H., (1981) Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease. Nature, 292, 768-770.
4. Wang, D.G., Fan, J.B., Siao, C.J., et al,. (1998) Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science, 280, 1077-1082.
5. Chistiakov, D.A., (2011) Genetic markers of Graves' disease: a historical view and up-date. British Journal of Medicine & Medical Research, 1, 538-568.
6. Wellcome Trust Case Control Consortium & The Australo-Anglo-American Spondylitis Consortium (TASC) (2007) Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nature Genetics, 39, 1329-1337.
7. Nakabayashi, K., Tajima, A., Yamamoto, K., et al,. (2011) Identification of independent risk loci for Graves' disease within the MHC in the Japanese population. Journal of human genetics, 56, 772-778.
8. Chu, X., Pan, C.M., Zhao, S.X., et al,. (2011) A genome-wide association study identifies two new risk loci for Graves' disease. Nature Genetics, 43, 897-901.
9. Brand, O.J., Lowe, C.E., Heward, J.M., et al,. (2007) Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clinical Endocrinology, 66, 508-512.
10. Chistiakov, D.A., Chistiakova, E.I., Voronova, N.V., et al,. (2011) A variant of the Il2RA/CD25 gene predisposing to Graves' disease is associated with increased levels of soluble interleukin-2 receptor. Scandinavian Journal of Immunology, 74, 496-501.
11. Howson, J.M., Walker, N.M., Smyth, D.J., et al,. (2009) Type I Diabetes Genetics Consortium. analysis of 19 genes for association with type I diabetes in the Type I Diabetes Genetics Consortium families. Genes and Immunity, 10, Suppl 1 S74-S84.
12. Kurreeman, F.A., Daha, N.A., Chang, M., et al,. (2009) Association of IL2RA and IL2RB with rheumatoid arthritis: a replication study in a Dutch population. Annals of the Rheumatic Diseases, 68, 1789-1790.
13. Hinks, A., Ke, X., Barton, A., et al,. (2009) Association of the IL2RA/CD25 gene with juvenile idiopathic arthritis. Arthritis and Rheumatism, 60, 251-257.
14. International Multiple Sclerosis Genetics Consortium, Hafler, D.A., Compston, A., et al,. (2007) Risk alleles for multiple sclerosis identified by a genomewide study. New England Journal of Medicine, 357, 851-862.
15. Perera, D., Stankovich, J., Butzkueven, H., et al,. (2009) Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus. Journal of Neuroimmunology, 211, 105-109.
16. Alcina, A., Fedetz, M., Ndagire, D., et al,. (2009) IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D). PLoS ONE, 4, e4137.
17. Paust, S., &, Cantor, H., (2005) Regulatory T cells and autoimmune disease. Immunological Reviews, 204, 195-207.
18. Mao, C., Wang, S., Xiao, Y., et al,. (2011) Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves' disease. The Journal of immunology, 186, 4734-4743.
19. Burchill, M.A., Yang, J., Vang, K.B., Farrar, M.A., (2007) Interleukin-2 receptor signaling in regulatory T cell development and homeostasis. Immunology Letters, 114, 1-8.
20. Willerford, D.M., Chen, J., Ferry, J.A., et al,. (1995) Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity, 3, 521-530.
21. Zwirska-Korczala, K., Berdowska, A., Jochem, J., et al,. (2004) Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders. Journal of Clinical Pharmacy and Thrapeutics, 29, 151-156.
22. Jiskra, J., Antosová, M., Límanová, Z., et al,. (2009) The relationship between thyroid function, serum monokine induced by interferon gamma and soluble interleukin-2 receptor in thyroid autoimmune diseases. Clinical and Experimental Immunology, 156, 211-216.
23. Song, H.D., Liang, J., Shi, J.Y., et al,. (2009) Functional SNPs in the SCGB3A2 promoter are associated with susceptibility to Graves' disease. Human molecular genetics, 18, 1156-1170.
24. Zhao, S.X., Pan, C.M., Cao, H.M., et al,. (2010) Association of the CTLA4 gene with Graves' disease in the Chinese Han population. PLoS ONE, 5, e9821.
25. Price, A.L., Patterson, N.J., Plenge, R.M., et al,. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nature Genetics, 38, 904-909.
26. Purcell, S., Neale, B., Todd-Brown, K., et al,. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. The American Journal of Human Genetics, 81, 559-575.
27. Aulchenko, Y.S., Struchalin, M.V., &, van Duijn, C.M., (2010) ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics, 11, 134-143.
28. Dixon, A.L., Liang, L., Moffatt, M.F., et al,. (2007) A genome-wide association study of global gene expression. Nature Genetics, 39, 1202-1207.
29. Zeller, T., Wild, P., Szymczak, S., et al,. (2007) Genetics and beyond-the transcriptome of human monocytes and disease susceptibility. PLoS ONE, 5, e10693.
30. Wacholder, S., Chanock, S., Garcia-Closas, M., et al,. (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. Journal of the National Cancer Institute, 96, 434-442.
31. Ueda, H., Howson, J.M.M., Esposito, L., et al,. (2003) Association of the T-cell regulatory gene CTLA 4 with susceptibility to autoimmune disease. Nature, 423, 506-511.
32. Cordell, H.J., &, Clayton, D.G., (2002) A unified stepwise regression procedure for evaluating the relative Effects of polymorphisms within a Gene using case/control or family data: application to[ITAL] HLA [/ITAL] in Type 1 diabetes. The American Journal of Human Genetics, 70, 124-141.
33. Dixon, A.L., Liang, L., Moffatt, M.F., et al,. (2007) A genome-wide association study of global gene expression. Nature Genetics, 39, 1202-1207.
34. Feldt-Rasmussen, U., Schleusener, H., &, Carayon, P., (1994) Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease. The Journal of Clinical Endocrinology & Metabolism, 78, 98-102.
35. Cappelli, C., Gandossi, E., Castellano, M., et al,. (2007) Prognostic value of thyrotropin receptor antibodies (TRAb) in Graves' disease: a 120 months prospective study. Endocrine Journal, 54, 713-720.
36. Duntas, L.H., (2008) Environmental factors and autoimmune thyroiditis. Nature Clinical Practice Endocrinology & Metabolism, 4, 454-460.
37. Safran, M., Paul, T.L., Roti, E., Braverman, L.E., (1987) Environmental factors affecting autoimmune thyroid disease. Endocrinology and Metabolism Clinics of North America, 16, 327-342.
38. Dunn, J.T., (1998) What's happening to our iodine? The Journal of Clinical Endocrinology & Metabolism, 83, 3398-3400.
39. Laurberg, P., Cerqueira, C., Ovesen, L., et al,. (2010) Iodine intake as a determinant of thyroid disorders in populations. Best Practice & Research: Clinical Endocrinology & Metabolism, 24, 13-27.
40. Weetman, A.P., &, McGregor, A.M., (1984) Autoimmune thyroid disease: developments in our understanding. Endocrine Reviews, 5, 309-355.
41. Thomas, S., Bayarri, M.J., &, BERGER, J.O., (2001) Calibration of p values for testing precise null hypotheses. The American Statistician, 55, 62-71.
42. Pearson, T.A., &, Manolio, T.A., (2008) How to interpret a genome-wide association study. The Journal of the American Medical Association, 299, 1335-1344.
43. Gauderman, W.J., &, Morrison, J.M.,. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies, http://hydra.usc.edu/gxe. (accessed January 2007).
44. Lee, S.H., Wray, N.R., Goddard, M.E., Visscher, P.M., (2011) Estimating missing heritability for disease from genome-wide association studies. The American Journal of Human Genetics, 88, 294-305.
45. Skõrka, A., Bednarczuk, T., Bar-Andziak, E., et al,. (2005) Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset. Clinical Endocrinology, 62, 679-682.
46. Velaga, M.R., Wilson, V., Jennings, C.E., et al,. (2004) The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. The Journal of Clinical Endocrinology & Metabolism, 89, 5862-5865.
47. Zhebrun, D., Kudryashova, Y., Babenko, A., et al,. (2011) Association of PTPN22 1858T/T genotype with type 1 diabetes, Graves' disease but not with rheumatoid arthritis in Russian population. AGING Journal, 3, 368-373.
48. Ban, Y., Tozaki, T., Taniyama, M., et al,. (2005) The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese. Thyroid, 15, 1115-1118.
49. Ichimura, M., Kaku, H., Fukutani, T., et al,. (2008) Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population. Thyroid, 18, 625-630.
50. Ban, Y., Tozaki, T., Taniyama, M., et al,. (2010) Association of the protein tyrosine phosphatase nonreceptor 22 haplotypes with autoimmune thyroid disease in the Japanese population. Thyroid, 20, 893-899.